Repaglinide 0.5 mg (Repaglinide TABLET) 0.5 MG

Repaglinide 0.5 mg tablets are oral medication used to manage blood sugar levels in diabetes. This fast-acting drug helps control glucose spikes after meals.

Strength

0.5 MG

Pack Size

100

Manufacturer / TM Owner

PRO DOC LIMITEE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Repaglinide 0.5 mg tablets are primarily used to manage type 2 diabetes by lowering blood sugar levels. This medication is often prescribed for individuals who require additional control of glucose spikes after meals. Repaglinide works by stimulating the pancreas to release more insulin, which helps the body process sugar more effectively. It is typically used alongside diet and exercise to maintain stable blood sugar levels throughout the day.

Side Effects

Common effects of Repaglinide 0.5 mg tablets may include mild to moderate hypoglycemia, which can cause symptoms such as sweating, dizziness, and hunger. Some users may also experience gastrointestinal discomfort, including nausea or diarrhea. These effects are generally temporary and may subside as the body adjusts to the medication. If symptoms persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Repaglinide 0.5 mg tablets should be handled with care, especially for individuals with a history of liver or kidney disease. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients should also monitor their blood sugar levels regularly and be aware of the signs of hypoglycemia. Always store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Repaglinide 0.5 mg tablets may interact with certain medications, including other diabetes drugs, antibiotics, and antifungal agents. Alcohol consumption should be avoided as it can enhance the hypoglycemic effects of Repaglinide. It is also important to inform healthcare providers about all current medications and supplements being taken to avoid potential interactions. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Repaglinide is used to manage blood sugar levels in individuals with type 2 diabetes, particularly to control glucose spikes after meals.

Repaglinide tablets are typically taken orally, usually before meals. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include hypoglycemia, gastrointestinal discomfort, and dizziness. These effects are usually temporary but should be monitored.

Repaglinide may interact with other medications, including diabetes drugs, antibiotics, and antifungals. Always consult a healthcare provider before combining medications.

Repaglinide should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.